hedgewing.ai vs Morningstar
If you want machine-learning price forecasts, walk-forward backtesting, and institutional-style quant risk metrics on US equities, hedgewing.ai is the closer fit; if you want human-analyst fundamental research, fair value estimates, star and economic-moat ratings, and whole-portfolio diagnostics across thousands of funds, ETFs, and stocks, Morningstar Investor is the closer fit. They solve different problems, and many serious investors use both.
hedgewing.ai (formerly Endeavr) is quantitative research tooling. It scores 229 US equities daily with a four-model deep-learning ensemble (LSTM, GRU, TCN, and Transformer) combined by a stacking meta-learner over 45 engineered features, attaches a calibrated confidence figure to every 1, 5, 10, and 20-day forecast, backtests walk-forward nightly, and reports risk analytics such as Sharpe, Sortino, VaR at 95 and 99 percent, Fama-French factor exposures, and HRP. It is priced for individuals, not desks.
Morningstar Investor is one of the most established names in independent investment research, built around analysis from a large global analyst team. Its strengths are fundamental research, fair value estimates, the well-known star and economic-moat ratings, screeners, and the Portfolio X-Ray tool that reveals true exposure and overlap across your holdings. Its breadth of fund and ETF coverage is far wider than hedgewing.ai's US-equity focus.
| Feature | hedgewing.ai | Morningstar |
|---|
| Starting price | Free tier with no card; Pro $19.99/mo or $199.99/yr; Workspace $49.99/mo | Morningstar Investor around $249/yr or about $34.95/mo (as of 2026); no permanent free plan |
| Free option | Permanent free tier: 5 analyses per day, no credit card required | 7-day free trial only; subscription required after that |
| AI / ML forecasting | Four-model deep-learning ensemble (LSTM, GRU, TCN, Transformer) plus stacking meta-learner; calibrated confidence on 1/5/10/20-day forecasts | No ML price forecasting; research is analyst-driven with fair value estimates and quantitative ratings |
| Backtesting | Walk-forward backtested nightly; backtested results shown with the usual caveats | Not a backtesting platform; focuses on forward-looking fundamental valuation and historical risk-adjusted ratings |
| Risk analytics | Sharpe, Sortino, VaR 95/99, Fama-French factor exposures, HRP | Portfolio X-Ray exposure analysis, risk and overlap diagnostics, style box, fund risk ratings |
| Data breadth | 229 US equities scored daily; research pages across thousands of US stocks and ETFs; US-equities focused | Very broad: thousands of mutual funds, ETFs, and stocks, plus deep fund data and global analyst coverage |
| Fundamental research | Daily AI briefs and a data-grounded chatbot; not human analyst reports | Core strength: written analyst reports, fair value estimates, star ratings, and economic-moat ratings |
| Portfolio tools | Portfolio-level quant risk metrics and forecasts | Portfolio X-Ray for true holdings exposure, overlap, and concentration across funds |
| API / team access | Workspace tier ($49.99/mo) adds API and team features | Consumer Investor product has no individual API; APIs sit in separate Morningstar Direct/enterprise products |
| Regulatory status | Not investment advice; not a registered adviser; backtested/past performance does not guarantee future results | Independent research provider; ratings and reports are research, not personalized advice |
Choose hedgewing.ai if you want affordable, quantitative US-equity tooling: ML forecasts with calibrated confidence, nightly walk-forward backtesting, and desk-style risk metrics (Sharpe, Sortino, VaR, Fama-French, HRP), with a genuinely free tier to start. Just remember it is US-equities research tooling, not a full data terminal or a broker, and not investment advice. Choose Morningstar Investor if you value independent human analyst research, fair value estimates, the established star and economic-moat ratings, and the broadest fund and ETF coverage with Portfolio X-Ray for whole-portfolio diagnostics, and you are comfortable paying around $249 a year after the trial. Long-term, buy-and-hold and fund-heavy investors tend to lean Morningstar; quantitatively minded equity investors who want models, backtests, and risk numbers tend to lean hedgewing.ai, and using both is a reasonable approach.